Prostate Cancer

Gordana Kocic, Full Professor of Biochemistry, Medical Faculty University Nis, Serbia.

Professor Gordana Kocic, MD, PhD is a Full Professor of Biochemistry at Medical Faculty University of Nis (Serbia). She is a specialist in medical biochemistry and a subspecialist in three areas of clinical biochemistry: immunoassays, biochemical oncology, and biochemical endocrinology. She is a full member of the Medical Department of the Medical Academy of the Serbian Medical Association, a member of the Scientific Council University of Nis, the Secretary of the Branch of the Academy of the Serbian Medical Association in Nis (Serbia). Professor Gordana Kocic's research has been published in 162 scientific papers in journals from the Journal Citation Report - SCI list, a significant amount of which are in the Q1 category; she is one of authors of textbooks: Biochemistry (Medical Faculty, University of Nis), Clinical Biochemistry (Medical Faculty University of Nis), and Selected Chapters in Urology (Institute for textbooks Belgrade); monographs: "Biochemistry of Free Radicals" and "Oxidative Modification of Biomolecules"; six chapters in monographs of national impact. She presented her scientific achievements published as supplements to prestigious journals. Four registrable patents provide as documentation of innovation activities. The prizes she received are: for PhD thesis, the best scientific articles awarded by the Serbian Medical Society branch Nis, the award for scientific achievement, "Best technological innovation for 2010", by Chamber of Commerce Republic Serbia's.  As a Principal Investigator of the projects of the Ministry of Education and Science Republic of Serbia and Fund of Science Republic of Serbia (No 7750154 (NPATPETTMPCB) and in the NETCHEM project, she has been overseeing and organizing a number of project research activities. She collaborated on two international bilateral projects with Slovenia and TEMPUS projects, Erasmus Plus project, the ERAWEB WB joint mobility program, and the SANU Branch projects.

 Jovan Hadzi-Djokic, Full Professor of Urology, Serbian Academy of Science and Arts, Belgrade, Serbia.

 Academician Prof. Jovan Hadzi-Djokic, MD, PhD  is a Full Professor of Urology spent almost his entire clinical and academic practice at University Clinical Center Medical Faculty Belgrade (Serbia), being the Director of the Institute of Urology and Nephrology of the Clinical Center of Serbia, a consultant for urology at the Institute of Oncology and Radiology of Serbia, at the Clinic for Gynecology and Obstetrics of the Clinical Center of Serbia. He is a Member of the Serbian Academy of Sciences and Arts since 2003. He trained at the Foch Hospital (Centre Medico Chirurgicale) in Paris (France) and at the University Urology Clinic in Florence (Italy). During his surgical carrier, he introduced new operative techniques into routine urological practice, which made highly respectable within the framework of European and world urology as a scientific discipline. Recognized as a renowned professor, urology expert and scientist, Academician Prof. Jovan Hadzi- okic enjoys a reputation in many professional associations through the world, as a member of the editorial boards of numerous journals. He published more than 500 professional-scientific papers, 11 monographs and textbooks in the field of urology: Tumors of the urinary bladder (1995), Angiographic atlas of urological diseases (1995), Urinary stoma (1996), Urgent urology (1997), Urological gynecology (2000), Minimal Invasion Treatment of Urinary Obstruction (2000), Localized prostate cancer ( 2005), Urinary diversions (2009), Urinary incontinence (2009), Erectile dysfunction (2012), Prostate (2014) and Hormones and Prostata (2022). He wrote more than 60 chapters in textbooks and monographs

Part I: Recent advances in prostate cancer etiology and pathogenesis.- Chapter 1: Prostate cancer: Epidemiology, etiology, and prostate cancer  risk factors.- Chapter 2: Genetic susceptibility to prostate cancer.- Chapter 3: Basic insights into tumor microenvironment in prostate cancer.- Chapter 4: Oxidative stress, redox signaling and apoptosis in prostate cancer development and progression.- Chapter 5: Epigenenomics, transriptomics and translational control in prostate cancer.- Chapter 6: Metabolic reprogramming as a prostate cancer hallmark.- Part II: An integrative approach in prostate cancer diagnostics.- Chapter 7: Diagnostic, prognostic and theranostic potential of miRNAs in prostate cancer.- Chapter 8: Diagnostic approaches of prostate cancer: when a biopsy is required?.- Chapter 9: Histopathological and molecular markers in assessment of prostate cancer aggressivity.- Chapter 10: Tumor markers in early detection and monitoring of prostate cancer: recent advances.-Chapter 11: Biological markers of therapeutic response in prostate cancer.- Part III: Current treatment options and monitoring of prostate cancer.- Chapter 12: Surgical treatment of prostate cancer.- Chapter 13: Robot-assisted laparoscopic radical prostatectomy.- Chapter 14: The use of apheresis in personalized cell-mediated treatment of prostate cancer.- Chapter 15: Hormone therapy for metastatic prostate cancer.- Chapter 16: Perspectives of immunotherapy for prostate cancer.- Chapter 17: Pharmacogenomics and precision therapy in prostate cancer: challenges and perspectives.- Chapter 18: Stereotactic radiotherapy in the treatment of prostate cancer.- Chapter 19: Treatment of castration-resistant prostate cancer.